Oliver Reuss
Executive Director / Investment Manager; Boehringer Ingelheim Venture Fund
Germany
39 investmentsOliver Reuss is an Executive Director / Investment Manager; Boehringer Ingelheim Venture Fund based in Germany. Oliver Reuss has backed 39 companies, including Aignostics, T3 Pharmaceuticals and Dopavision. Investment focus areas include Health Care, Hospitals and Wellness.
Sign up to access email, LinkedIn & portfolio
Investment Focus
Portfolio Companies (39)
| Industry | Stage | Website | |||
|---|---|---|---|---|---|
| 1 | Aignostics | — | — | — | — |
| 2 | T3 Pharmaceuticals | — | — | — | — |
| 3 | Dopavision | — | — | — | — |
| 4 | Topas Therapeutics | — | — | — | — |
| 5 | Actym | — | — | — | — |
| 6 | eTheRNA immunotherapies | — | — | — | — |
| 7 | STAT-Dx | — | — | — | — |
| 8 | Rinri Therapeutics | — | — | — | — |
| 9 | Rigontec | — | — | — | — |
| 10 | Hookipa Pharma | — | — | — | — |
| 11 | Tacalyx | — | — | — | — |
| 12 | NBE-Therapeutics | — | — | — | — |
Showing 1–12 of 39
Page 1 of 4
Access Full Contact Information
Get Oliver Reuss's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.
Email
LinkedIn
Portfolio
No credit card required